Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-180865
Filing Date
2025-08-14
Accepted
2025-08-14 16:46:26
Documents
90
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A eldn-20241231.htm   iXBRL 10-K/A 4326476
2 EX-23.1 eldn-ex23_1.htm EX-23.1 6469
3 EX-23.2 eldn-ex23_2.htm EX-23.2 5499
4 EX-31.3 eldn-ex31_3.htm EX-31.3 18302
5 EX-31.4 eldn-ex31_4.htm EX-31.4 18555
6 EX-32.3 eldn-ex32_3.htm EX-32.3 9815
7 EX-32.4 eldn-ex32_4.htm EX-32.4 9639
8 GRAPHIC img117130267_0.jpg GRAPHIC 868165
9 GRAPHIC img117130267_1.jpg GRAPHIC 273026
10 GRAPHIC img117130267_2.jpg GRAPHIC 154264
11 GRAPHIC img117130267_3.jpg GRAPHIC 119803
  Complete submission text file 0001193125-25-180865.txt   19949453

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20241231.xsd EX-101.SCH 1579494
93 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20241231_htm.xml XML 3790526
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 251220372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)